Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс: http://elar.urfu.ru/handle/10995/102931
Полная запись метаданных
Поле DCЗначениеЯзык
dc.contributor.authorde, Munter, J.en
dc.contributor.authorPavlov, D.en
dc.contributor.authorGorlova, A.en
dc.contributor.authorSicker, M.en
dc.contributor.authorProshin, A.en
dc.contributor.authorKalueff, A. V.en
dc.contributor.authorSvistunov, A.en
dc.contributor.authorKiselev, D.en
dc.contributor.authorNedorubov, A.en
dc.contributor.authorMorozov, S.en
dc.contributor.authorUmriukhin, A.en
dc.contributor.authorLesch, K. -P.en
dc.contributor.authorStrekalova, T.en
dc.contributor.authorSchroeter, C. A.en
dc.date.accessioned2021-08-31T15:06:26Z-
dc.date.available2021-08-31T15:06:26Z-
dc.date.issued2021-
dc.identifier.citationIncreased Oxidative Stress in the Prefrontal Cortex as a Shared Feature of Depressive- and PTSD-Like Syndromes: Effects of a Standardized Herbal Antioxidant / J. de Munter, D. Pavlov, A. Gorlova, et al. — DOI 10.3389/fnut.2021.661455 // Frontiers in Nutrition. — 2021. — Vol. 8. — 661455.en
dc.identifier.issn2296861X-
dc.identifier.otherFinal2
dc.identifier.otherAll Open Access, Gold, Green3
dc.identifier.otherhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85105188741&doi=10.3389%2ffnut.2021.661455&partnerID=40&md5=e76c95a75e932aedbf1e05be475e95db
dc.identifier.otherhttps://www.frontiersin.org/articles/10.3389/fnut.2021.661455/pdfm
dc.identifier.urihttp://elar.urfu.ru/handle/10995/102931-
dc.description.abstractMajor depression (MD) and posttraumatic stress disorder (PTSD) share common brain mechanisms and treatment strategies. Nowadays, the dramatically developing COVID-19 situation unavoidably results in stress, psychological trauma, and high incidence of MD and PTSD. Hence, the importance of the development of new treatments for these disorders cannot be overstated. Herbal medicine appears to be an effective and safe treatment with fewer side effects than classic pharmaca and that is affordable in low-income countries. Currently, oxidative stress and neuroinflammation attract increasing attention as important mechanisms of MD and PTSD. We investigated the effects of a standardized herbal cocktail (SHC), an extract of clove, bell pepper, basil, pomegranate, nettle, and other plants, that was designed as an antioxidant treatment in mouse models of MD and PTSD. In the MD model of “emotional” ultrasound stress (US), mice were subjected to ultrasound frequencies of 16–20 kHz, mimicking rodent sounds of anxiety/despair and “neutral” frequencies of 25–45 kHz, for three weeks and concomitantly treated with SHC. US-exposed mice showed elevated concentrations of oxidative stress markers malondialdehyde and protein carbonyl, increased gene and protein expression of pro-inflammatory cytokines interleukin (IL)-1β and IL-6 and other molecular changes in the prefrontal cortex as well as weight loss, helplessness, anxiety-like behavior, and neophobia that were ameliorated by the SHC treatment. In the PTSD model of the modified forced swim test (modFST), in which a 2-day swim is followed by an additional swim on day 5, mice were pretreated with SHC for 16 days. Increases in the floating behavior and oxidative stress markers malondialdehyde and protein carbonyl in the prefrontal cortex of modFST-mice were prevented by the administration of SHC. Chromatography mass spectrometry revealed bioactive constituents of SHC, including D-ribofuranose, beta-D-lactose, malic, glyceric, and citric acids that can modulate oxidative stress, immunity, and gut and microbiome functions and, thus, are likely to be active antistress elements underlying the beneficial effects of SHC. Significant correlations of malondialdehyde concentration in the prefrontal cortex with altered measures of behavioral despair and anxiety-like behavior suggest that the accumulation of oxidative stress markers are a common biological feature of MD and PTSD that can be equally effectively targeted therapeutically with antioxidant therapy, such as the SHC investigated here. © Copyright © 2021 de Munter, Pavlov, Gorlova, Sicker, Proshin, Kalueff, Svistunov, Kiselev, Nedorubov, Morozov, Umriukhin, Lesch, Strekalova and Schroeter.en
dc.description.sponsorshipWe thank Maria Shoshorina, Laboratory of Psychiatric Neurobiology, Sechenov University for providing excellent technical assistance for providing herbal cocktail and solvent, Neuroplast BV, The Netherlands, for technical and material support, Rene Vendeville, Voorhout, The Netherlands and Vsevolod G. Pinelis for valuable conceptual and methodological input and discussions. This publication was supported by the Open Access Publication Fund of the University of Wuerzburg. Funding. This study was supported by the Horizon 2020 Research and Innovation Program under Grant No. 728018 (Eat2beNICE) to K-PL and TS and Grant No. 101007642 (PhytoAPP, H2020-MSCA-RISE-2020) to TS and JM.en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherFrontiers Media S.A.en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.sourceFront. Nutr.2
dc.sourceFrontiers in Nutritionen
dc.subjectANTIOXIDANT NUTRIENTSen
dc.subjectDEPRESSIONen
dc.subjectFORCED SWIMMINGen
dc.subjectMICEen
dc.subjectOXIDATIVE STRESSen
dc.subjectPOST-TRAUMATIC STRESS DISORDERen
dc.subjectPREFRONTAL CORTEXen
dc.subjectPRO-INFLAMMATORY CYTOKINESen
dc.titleIncreased Oxidative Stress in the Prefrontal Cortex as a Shared Feature of Depressive- and PTSD-Like Syndromes: Effects of a Standardized Herbal Antioxidanten
dc.typeArticleen
dc.typeinfo:eu-repo/semantics/articleen
dc.typeinfo:eu-repo/semantics/publishedVersionen
dc.identifier.rsi46037471-
dc.identifier.doi10.3389/fnut.2021.661455-
dc.identifier.scopus85105188741-
local.contributor.employeede Munter, J., Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands
local.contributor.employeePavlov, D., Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation
local.contributor.employeeGorlova, A., Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation
local.contributor.employeeSicker, M., Rehabilitation Research Unit of Clinic of Bad Kreuzbach, Bad Kreuzbach, Germany
local.contributor.employeeProshin, A., PK Anokhin Research Institute of Normal Physiology, Moscow, Russian Federation
local.contributor.employeeKalueff, A.V., Ural Federal University, Yekaterinburg, Russian Federation, Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russian Federation, Neuroscience Program, Sirius University, Sochi, Russian Federation, School of Biological and Medical Physics, Moscow Institute of Physics and Technology, Moscow, Russian Federation
local.contributor.employeeSvistunov, A., Institute for Translational Medicine and Biotechnology, Preclinical Research Center of Sechenov First, Moscow State Medical University, Moscow, Russian Federation
local.contributor.employeeKiselev, D., Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation, Institute for Translational Medicine and Biotechnology, Preclinical Research Center of Sechenov First, Moscow State Medical University, Moscow, Russian Federation, Federal Budgetary Institute of General Pathology and Pathophysiology, Moscow, Russian Federation
local.contributor.employeeNedorubov, A., Institute for Translational Medicine and Biotechnology, Preclinical Research Center of Sechenov First, Moscow State Medical University, Moscow, Russian Federation
local.contributor.employeeMorozov, S., Federal Budgetary Institute of General Pathology and Pathophysiology, Moscow, Russian Federation
local.contributor.employeeUmriukhin, A., Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation
local.contributor.employeeLesch, K.-P., Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation, Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany
local.contributor.employeeStrekalova, T., Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation, Federal Budgetary Institute of General Pathology and Pathophysiology, Moscow, Russian Federation, Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany
local.contributor.employeeSchroeter, C.A., Department of Preventive Medicine, Maastricht Medical Center Annadal, Maastricht, Netherlands
local.volume8-
dc.identifier.wos000645656400001-
local.contributor.departmentDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands
local.contributor.departmentLaboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation
local.contributor.departmentRehabilitation Research Unit of Clinic of Bad Kreuzbach, Bad Kreuzbach, Germany
local.contributor.departmentPK Anokhin Research Institute of Normal Physiology, Moscow, Russian Federation
local.contributor.departmentUral Federal University, Yekaterinburg, Russian Federation
local.contributor.departmentInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russian Federation
local.contributor.departmentNeuroscience Program, Sirius University, Sochi, Russian Federation
local.contributor.departmentSchool of Biological and Medical Physics, Moscow Institute of Physics and Technology, Moscow, Russian Federation
local.contributor.departmentInstitute for Translational Medicine and Biotechnology, Preclinical Research Center of Sechenov First, Moscow State Medical University, Moscow, Russian Federation
local.contributor.departmentFederal Budgetary Institute of General Pathology and Pathophysiology, Moscow, Russian Federation
local.contributor.departmentDivision of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany
local.contributor.departmentDepartment of Preventive Medicine, Maastricht Medical Center Annadal, Maastricht, Netherlands
local.identifier.pure21867906-
local.identifier.pure515f285c-57b3-4356-84a5-4d2f43432ba1uuid
local.description.order661455-
local.identifier.eid2-s2.0-85105188741-
local.fund.cordis101007642-
local.fund.cordis728018-
local.identifier.wosWOS:000645656400001-
Располагается в коллекциях:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Файлы этого ресурса:
Файл Описание РазмерФормат 
2-s2.0-85105188741.pdf1,57 MBAdobe PDFПросмотреть/Открыть


Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.